Navigation Links
MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio
Date:2/7/2008

GAITHERSBURG, Md., Feb. 7 /PRNewswire/ -- MedImmune today announced that it has strengthened its leadership in research, human resources (HR) and regulatory affairs with three key promotions and has also hired a new head of vaccine manufacturing. Peter A. Kiener, D. Phil. has been appointed to executive vice president, research; Katy Strei to vice president, people and organization development, HR; and Eileen Valenta to vice president, operations and compliance, regulatory affairs. In addition, Shou-Bai Chao, Ph.D. has recently joined the company as vice president of vaccine manufacturing.

"As MedImmune prepares for the next phase of its corporate growth -- including dramatic acceleration within its product portfolio, it is imperative that we have strong leadership at the helm of all aspects of our business, but particularly within the research, HR and regulatory affairs functions," said David M. Mott, chief executive officer and president.

"Peter is now driving forward our global research efforts, which span from our core antibody research center in Maryland's biotech corridor to our discovery and development center in Cambridge, UK to our vaccine research facilities in the San Francisco Bay area of California. Katy is ensuring that we have the right people -- with the right skills -- at the right time, which is critical for us to deliver on the promise of our pipeline. Eileen's contributions will grow significantly with our maturing product portfolio and its need for regulatory affairs and compliance oversight. And, as we carry forward the potential next-generation of innovative vaccines, Shou-Bai is a welcome addition to the organization," Mott added.

Management Promotions

Dr. Peter Kiener has been promoted from senior vice president, research to executive vice president, research, overseeing all global research activities for the company. Since joining MedImmune in 2001, Dr. Kiener has made expert and strategic contributions in
'/>"/>

SOURCE MedImmune
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. MedImmune Submits Biologics License Application to FDA for Motavizumab
2. MedImmune Broadens Focus of Venture Capital Fund to Include New Therapeutic Areas
3. MedImmune Announces Seven Key Promotions and New Hires
4. AstraZeneca Bolsters Its Worldwide Biologics Division Through Integration of Cambridge Antibody Technology Into MedImmune
5. MedImmune to Present RSV Surveillance and Cost-Effectiveness Data at American Academy of Pediatrics National Conference & Exhibition
6. MedImmune Recognized by Local Volunteer Organization for Its Employees Exceptional Commitment to Community Service within Montgomery County
7. MedImmune Celebrates Opening of New Pilot Lab at Gaithersburg Headquarters
8. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
9. BioCryst Strengthens Its Expertise in Clinical Development By Adding Thomas J. Simon, M.D. as Interim Chief Medical Officer To Meet Growing Product Development and Commercial Opportunities
10. Anavex strengthens Board of Directors
11. PAREXEL Appoints Charles A. Stevens as Vice President/General Manager of Health Policy and Strategic Reimbursement and Strengthens Capabilities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... (PRWEB) February 26, 2015 Innovation ... are emerging from unexpected parts of the world ... From agriculture to manufacturing to health care, ... and environmental realities and socio-political trends shake the ... the key ingredient for CEOs to survive the ...
(Date:2/26/2015)... Regis Technologies announced new potent ... drug substances. , Regis Technologies is proud to announce ... Compound Suite (PCS) for 2015. , Regis is a ... facility in Morton Grove, Illinois. The PCS addition will ... up to about one kilogram per batch. , ...
(Date:2/26/2015)... 26, 2015   Lexicon Pharmaceuticals, Inc. (Nasdaq: ... at the Cowen 35 th Annual Health Care Conference ... Boston .  Lexicon management will provide an ... A webcast of the presentation will be available through Lexicon,s ... presentation will be available at www.lexpharma.com until April ...
(Date:2/26/2015)... , Feb. 26, 2015 Caris ... posters, at the 2015 Genitourinary Cancers Symposium in ... the clinical utility of tumor profiling. Both studies ... tumor profiling service, to identify biomarkers that shed ... cancer and small cell bladder cancer (SCBC). ...
Breaking Biology Technology:One Million Acts of Innovation Canada Creates Partnership with The Economist Events’ Innovation Forum 2Regis Extends cGMP Services to Oncology Market 2Lexicon To Present At The Cowen 35th Annual Health Care Conference 2Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with Caris Molecular Intelligence Yields Insights into Novel and Conventional Therapeutic Options 2Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with Caris Molecular Intelligence Yields Insights into Novel and Conventional Therapeutic Options 3Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with Caris Molecular Intelligence Yields Insights into Novel and Conventional Therapeutic Options 4Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with Caris Molecular Intelligence Yields Insights into Novel and Conventional Therapeutic Options 5
... 30 Biotel Inc. (OTC Bulletin Board: BTEL) announced results ... earnings of $944,000, or $0.33 per diluted share, on revenues ... or $0.23 per diluted share on revenues of $11,495,000 in ... reported net earnings of $174,000 or $0.06 per diluted share, ...
... N.J., Sept. 30 DOR BioPharma, Inc. (OTC Bulletin Board: ... completed a corporate name change from DOR BioPharma, Inc. to ... the name change, the Company,s shares of common stock will ... of today. , "We are pleased to announce ...
... Valentine aka "DoctorLoopy" Wins Grand Prize with One-of-a-kind Video from Big Bend ... Voted for the Best Video Response to: "What Do America,s National Parks ... Park Foundation and Olympus announced today that ... TX, is the grand prize winner of the " Your Parks" ...
Cached Biology Technology:Biotel Announces Fourth Quarter and Year End Results 2DOR BioPharma Announces Corporate Name Change to Soligenix and Begins Trading Under New Ticker Symbol 'SNGX' 2DOR BioPharma Announces Corporate Name Change to Soligenix and Begins Trading Under New Ticker Symbol 'SNGX' 3DOR BioPharma Announces Corporate Name Change to Soligenix and Begins Trading Under New Ticker Symbol 'SNGX' 4The National Park Foundation and Olympus Announce Winner of the First-Ever 'Your Parks' Video Challenge 2The National Park Foundation and Olympus Announce Winner of the First-Ever 'Your Parks' Video Challenge 3The National Park Foundation and Olympus Announce Winner of the First-Ever 'Your Parks' Video Challenge 4
(Date:2/5/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD and ... focused on the growing mobile commerce market, announces it ... Conference on January 29 th at 10:30 a.m. ... of NXT-ID will present and host a live Q&A ... and its full suite of biometric technologies. Investors can ...
(Date:1/22/2015)... , Jan. 22, 2015 Research and Markets ... "Biometrics - A Global Market Overview" report to their ... technology is to ensure that an individual is who she/he ... may make use of a person,s unique physical characteristics, such ...
(Date:1/22/2015)... 2015 Technology Showcase, Hall E -   EyeLock Inc. ... announced it will showcase its EyeLock ID technology integrated in ... of Energy,s Oak Ridge National Laboratory (ORNL) at ... iris identity authentication technology is being used to validate the ...
Breaking Biology News(10 mins):CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3
... Fungi play key roles in nature and are valued for ... in several foods and pharmaceuticals produced on a large-scale basis for ... . While A. niger is an integral player in ... be deployed in breaking down plant cell walls to free up ...
... has a photo of a cornfield and a big photovoltaic ... Washington University in St. Louis. "When I give talks I ... the audience votes overwhelmingly in favor of photosynthesis. " ... (below) is the point of departure for a provocative article ...
... (May 3, 2011) Cancer studies from Mercer University ... the American Association of Pharmaceutical Scientists, (AAPS) National Biotechnology ... -Wednesday, May 18 at the Hilton San Francisco Union ... for Cervical Cancer Cervical cancer is the ...
Cached Biology News:Same fungus, different strains 2Same fungus, different strains 3Turning plants into power houses 2Turning plants into power houses 3Turning plants into power houses 4Turning plants into power houses 5Turning plants into power houses 6AAPS national biotechnology conference to highlight breakthrough cancer treatments 2
Rad51B...
... to Ki67 - Proliferation Marker, prediluted ... related nuclear protein, expressed by proliferating cells ... cycle (G1, S, G2 and M phase). ... Ki67 antibodies are useful in establishing the ...
... monoclonal antibody reactive against the complex IV assembly ... in growing cultured cells. SURF1 is an important ... thought to participate in the folding of subunit ... Mutations of SURF1, particularly ones that result in ...
Phenytoin-BSA Isolated IgY DFc Drug...
Biology Products: